Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.34 |
| ▸ | ESR1 | P03372 | 2/20 | 0.34 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.34 |
| ▸ | TACR2 | P21452 | 2/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | SHBG | P04278 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.34 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4586387 | 1.00 | KCNH2 (0.47) | KCNH2ALDH1A1PKMHPGDPTGS2 | |
| SCHEMBL4584661 | 1.00 | KCNH2 (0.47) | KCNH2ALDH1A1PKMHPGDPTGS2 | |
| SCHEMBL4584001 | 1.00 | KCNH2 (0.47) | KCNH2ALDH1A1PKMHPGDPTGS2 | |
| SCHEMBL4583274 | 1.00 | KCNH2 (0.47) | KCNH2ALDH1A1PKMHPGDPTGS2 | |
| SCHEMBL11478223 | 1.00 | KCNH2 (0.47) | KCNH2ALDH1A1PKMHPGDPTGS2 | |
| SCHEMBL4584718 | 1.00 | KCNH2 (0.47) | KCNH2ALDH1A1PKMHPGDPTGS2 | |
| SCHEMBL4585305 | 1.00 | KCNH2 (0.47) | KCNH2ALDH1A1PKMHPGDPTGS2 | |
| SCHEMBL11462779 | 1.00 | KCNH2 (0.47) | KCNH2ALDH1A1PKMHPGDPTGS2 | |
| SCHEMBL244220 | 0.98 | KCNH2 (0.44) | KCNH2ALDH1A1PKMHPGDPTGS2 | |
| SCHEMBL559033 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8334391-B2 | Functionalized heteroacenes | XEROX CORPORATION (US) | 2012-12-18 | — | — | US | claimed |
| US-7372071-B2 | Functionalized heteroacenes and electronic devices generated therefrom | XEROX CORPORATION (US) | 2008-05-13 | — | — | US | claimed |
| US-20070260069-A1 | Functionalized heteroacenes | XEROX CORPORATION | 2007-11-08 | — | — | US | claimed |
| US-20070235721-A1 | Functionalized heteroacenes and electronic devices generated therefrom | XEROX CORPORATION | 2007-10-11 | — | — | US | claimed |
| EP-1843410-B1 | Functionalized heteroacenes and electronic devices generated therefrom | XEROX CORP (US) | 2013-10-16 | — | — | EP | disclosed |
| EP-1843410-A2 | Functionalized heteroacenes and electronic devices generated therefrom | Xerox Corporation (US) | 2007-10-10 | — | — | EP | disclosed |
| US-4201779-A | 7[(2-Amino-thiazol-4-yl)glyoxylamido]-cephem derivatives and processes for their preparation | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-05-06 | — | — | US | disclosed |
| US-4016159-A | BACTERICIDES | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070260069-A1 | Functionalized heteroacenes | SOD1, AHR, NR0B2 | KCNH2 1459/4885ALDH1A1 2135/4885PKM 3237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.